Andere Kunden interessierten sich auch für
![The Role of Complement in Cancer Immunotherapy]( "The Role of Complement in Cancer Immunotherapy")
The Role of Complement in Cancer Immunotherapy63,99 €![The Song of the Cell]( "The Song of the Cell")
The Song of the Cell38,99 €![Tumor Immunology and Immunotherapy Resistance]( "Tumor Immunology and Immunotherapy Resistance")
Tumor Immunology and Immunotherapy Resistance85,99 €![COVID-19 and Gastrointestinal Disease]( "COVID-19 and Gastrointestinal Disease")
COVID-19 and Gastrointestinal Disease73,99 €![Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy]( "Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy")
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy81,99 €![Metastatic Progression and Tumour Heterogeneity]( "Metastatic Progression and Tumour Heterogeneity")
Metastatic Progression and Tumour Heterogeneity96,99 €![The 5th International Congress of CiiEM -Reducing inequalities in Health and Society]( "The 5th International Congress of CiiEM -Reducing inequalities in Health and Society")
The 5th International Congress of CiiEM -Reducing inequalities in Health and Society51,99 €
Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this hematological malignancy.